18:04 , Jul 10, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Prostate cancer Cell culture studies identified a compound that recruits androgen receptor to IAP for proteasomal degradation that could help treat prostate cancer. The compound consisted of an androgen receptor ligand and a peptidomimetic...
07:00 , Aug 21, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Androgen receptor (AR); prostate-specific antigen (KLK3; PSA) In vitro studies have identified indole carboxamide-based AR inhibitors that could help treat prostate cancer. In...
07:00 , Aug 28, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Androgen receptor (AR) Studies in cell culture and in mice suggest that targeting AR in the tumor epithelium...
08:00 , Mar 11, 2002 |  BioCentury  |  Strategy

Schering looks to acquire elsewhere

Schering looks to acquire elsewhere Product Indication Partner Status Market launch Oncology Androcur Prostate cancer Marketed 1970s (Europe) Bonefos Hypercalcaemia and osteolysis in malignancies Marketed 1990 (Europe) Fludara CLL Marketed 1991 (U.S.), 1994 (Europe) Campath...